{"id":"clm_4C12B1C9DF34","entity":"eli-lilly","predicate":"shares_outstanding","value":"1,103,388,743 shares","value_json":{"fp":"Q1","fy":2017,"accn":"0000059478-17-000129","form":"10-Q","filed":"2017-05-01","period":"Q1 FY2017","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2017-04-24","valid_to":"2017-07-17","published":"2017-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Eli Lilly and Company shares outstanding: 1,103,388,743 shares\", as of 2017-04-24 (until 2017-07-17). Claim clm_4C12B1C9DF34, https://asof.is/claim/clm_4C12B1C9DF34, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947817000129/0000059478-17-000129-index.htm.","url":"https://asof.is/claim/clm_4C12B1C9DF34","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BB222876F045","supersedes":["clm_ABD29EC217BC"],"first_seen_at":"2026-11-08T15:32:14.384194+00:00","updated_at":"2026-11-08T15:32:18.231201+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000129/0000059478-17-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-01"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}